Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases

Y Wang, X Yu, E Chen, L Li - Stem cell research & therapy, 2016 - Springer
Mesenchymal stem cells (MSCs) represent an attractive cell type for research and therapy
due to their ability to proliferate, differentiate, modulate immune reactions, and secrete …

Current Perspectives Regarding Stem Cell‐Based Therapy for Liver Cirrhosis

KA Kwak, HJ Cho, JY Yang… - Canadian Journal of …, 2018 - Wiley Online Library
Liver cirrhosis is a major cause of mortality and a common end of various progressive liver
diseases. Since the effective treatment is currently limited to liver transplantation, stem cell …

[HTML][HTML] Stem cell-based regenerative opportunities for the liver: State of the art and beyond

E Tsolaki, E Yannaki - World journal of gastroenterology, 2015 - ncbi.nlm.nih.gov
The existing mismatch between the great demand for liver transplants and the number of
available donor organs highlights the urgent need for alternative therapeutic strategies in …

Personalized nanomedicine advancements for stem cell tracking

M Janowski, JWM Bulte, P Walczak - Advanced drug delivery reviews, 2012 - Elsevier
Recent technological developments in biomedicine have facilitated the generation of data
on the anatomical, physiological and molecular level for individual patients and thus …

Sodium butyrate promotes the differentiation of rat bone marrow mesenchymal stem cells to smooth muscle cells through histone acetylation

J Liu, Y Wang, Y Wu, B Ni, Z Liang - PloS one, 2014 - journals.plos.org
Establishing an effective method to improve stem cell differentiation is crucial in stem cell
transplantation. Here we aimed to explore whether and how sodium butyrate (NaB) induces …

Potential and challenges of induced pluripotent stem cells in liver diseases treatment

Y Yu, X Wang, SL Nyberg - Journal of clinical medicine, 2014 - mdpi.com
Tens of millions of patients are affected by liver disease worldwide. Many of these patients
can benefit from cell therapy involving living metabolically active cells, either by treatment of …

[PDF][PDF] 人源诱导多能干细胞体外定向分化为功能性肝细胞的方法研究

邵文桂, 张阳, 阮海文, 窦金辉, 张雪峰… - 现代生物医学 …, 2023 - biomed.cnjournals.com
摘要目的: 研究开发一种简易, 快速在体外使多能诱导干细胞(induced pluripotent stem cells,
iPSCs) 定向分化为功能性肝样细胞的培养方法. 方法: 根据正常肝细胞在体内的发育规律 …

Hepatocytic differentiation of iPS cells on decellularized liver tissue

M Hirata, T Yamaoka - Journal of Artificial Organs, 2017 - Springer
Decellularized tissues (DETs) have been attracting great attention as scaffolds for tissue-
engineering approaches. Recently, some studies have reported that decellularized liver …

High efficient differentiation of functional hepatocytes from porcine induced pluripotent stem cells

Y Ao, JD Mich-Basso, B Lin, L Yang - PloS one, 2014 - journals.plos.org
Hepatocyte transplantation is considered to be a promising therapy for patients with liver
diseases. Induced pluripotent stem cells (iPSCs) provide an unlimited source for the …

Cell-based therapies of liver diseases: age-related challenges

KN Yarygin, AY Lupatov… - Clinical Interventions in …, 2015 - Taylor & Francis
The scope of this review is to revise recent advances of the cell-based therapies of liver
diseases with an emphasis on cell donor's and patient's age. Regenerative medicine with …